Stericycle’s (SRCL) Overweight Rating Reaffirmed at Barclays PLC
Barclays PLC restated their overweight rating on shares of Stericycle, Inc. (NASDAQ:SRCL) in a research report released on Wednesday morning. The firm currently has a $100.00 price objective on the business services provider’s stock.
Other analysts also recently issued research reports about the stock. Jefferies Group LLC set a $108.00 target price on shares of Stericycle and gave the stock a buy rating in a research report on Saturday, May 6th. BMO Capital Markets began coverage on shares of Stericycle in a research report on Thursday, June 29th. They set a market perform rating and a $81.00 target price on the stock. Zacks Investment Research downgraded shares of Stericycle from a buy rating to a hold rating in a research report on Monday, August 7th. BidaskClub raised shares of Stericycle from a strong sell rating to a sell rating in a research report on Monday, July 24th. Finally, Robert W. Baird downgraded shares of Stericycle from a neutral rating to an underperform rating and dropped their target price for the stock from $74.00 to $73.00 in a research report on Monday, May 15th. Four research analysts have rated the stock with a sell rating, six have issued a hold rating and six have issued a buy rating to the company’s stock. The company has a consensus rating of Hold and a consensus target price of $81.15.
Shares of Stericycle (NASDAQ:SRCL) traded down 0.57% during midday trading on Wednesday, reaching $71.03. 1,349,933 shares of the company’s stock were exchanged. The company’s market cap is $6.06 billion. The stock’s 50 day moving average price is $76.45 and its 200 day moving average price is $80.44. Stericycle has a 12-month low of $70.24 and a 12-month high of $88.00.
Stericycle (NASDAQ:SRCL) last released its earnings results on Thursday, August 3rd. The business services provider reported $1.15 earnings per share for the quarter, topping the consensus estimate of $1.13 by $0.02. The company had revenue of $917.70 million for the quarter, compared to the consensus estimate of $902.81 million. Stericycle had a negative net margin of 0.07% and a positive return on equity of 14.35%. Stericycle’s revenue was up 2.9% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.18 EPS. Equities analysts anticipate that Stericycle will post $4.60 earnings per share for the current fiscal year.
WARNING: This article was reported by TheOlympiaReport and is owned by of TheOlympiaReport. If you are accessing this article on another domain, it was illegally stolen and republished in violation of United States and international trademark and copyright laws. The original version of this article can be accessed at https://theolympiareport.com/2017/08/12/stericycles-srcl-overweight-rating-reaffirmed-at-barclays-plc.html.
Hedge funds have recently made changes to their positions in the stock. Kernodle & Katon Asset Management Group LLC acquired a new stake in shares of Stericycle during the first quarter valued at approximately $100,000. Heritage Trust Co acquired a new stake in shares of Stericycle during the first quarter valued at approximately $124,000. Pacer Advisors Inc. boosted its stake in shares of Stericycle by 8.4% in the second quarter. Pacer Advisors Inc. now owns 1,880 shares of the business services provider’s stock valued at $143,000 after buying an additional 145 shares during the last quarter. Invictus RG acquired a new stake in shares of Stericycle during the first quarter valued at approximately $145,000. Finally, Morgan Dempsey Capital Management LLC boosted its stake in shares of Stericycle by 2.6% in the first quarter. Morgan Dempsey Capital Management LLC now owns 1,902 shares of the business services provider’s stock valued at $158,000 after buying an additional 48 shares during the last quarter. Institutional investors and hedge funds own 95.16% of the company’s stock.
Stericycle, Inc is a business-to-business services provider. The Company focuses on regulated and compliance solutions for healthcare, retail, and commercial businesses. The Company’s segments include Domestic and Canada Regulated Waste and Compliance Services (RCS), Domestic Communication and Related Services (CRS), International RCS and All other.
Receive News & Ratings for Stericycle Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.